NewEdge Advisors’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,080	Closed	-$38.6K	–	4123
2025 Q1	$38.6K	Buy	+15,080	New	+$38.6K	﹤0.01%	2639
2023 Q3	–	Sell	-536	Closed	-$1.07K	–	3613
2023 Q2	$1.07K	Buy	+536	New	+$1.07K	﹤0.01%	3236